ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Pharmacological Research
Volume 53, Issue 4, April 2006, Pages 324-330
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (396 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.phrs.2005.12.010    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2006 Elsevier Ltd All rights reserved.

Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ali Mustafaa, Azza El-Medanya, Hanan H. Hagara, Corresponding Author Contact Information, E-mail The Corresponding Author and Gamila El-Medanyb

aDepartment of Pharmacology, College of Medicine & KKUH, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi Arabia

bDepartment of Anatomy, College of Medicine & KKUH, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi Arabia


Accepted 29 December 2005. 
Available online 3 February 2006.

Abstract

Intestinal inflammatory states, regardless of specific initiating events, share common immunologically mediated pathways of tissue injury and repair. The efficacy of various drugs used to treat ulcerative colitis (UC) was investigated. The aim of the present study is to evaluate the effects of ginkgo biloba extract on the extent and severity of UC caused by intracolonic administration of acetic acid in rats. The inflammatory response was assessed by histology and measurement of myeloperoxidase activity (MPO), reduced glutathione (GSH), tumor necrosis factor (TNF-α) and interleukin-1β (IL-1β) levels in colon mucosa. Oral pretreatment with Ginkgo biloba in doses of (30, 60, 120 mg kg−1 body weight) and sulfasalazine in a dose of (500 mg kg−1 body weight used as reference) for 2 days before induction of colitis and continued for 5 consecutive days, significantly decreased colonic MPO activity, TNF-α, and IL-1β levels and increased GSH concentration. Moreover, Ginkgo biloba attenuated the macroscopic colonic damage and the histopathological changes-induced by acetic acid. These results suggest that Ginkgo biloba may be effective in the treatment of UC through its scavenging effect on oxygen-derived free radicals.

Keywords: Ginkgo biloba; Interleukin-1β; Tumor necrosis factor-α; Oxidative stress; Myeloperoxidase; Reduced glutathione; Thiobarbituric acid reactive substances; Acetic acid-induced colitis

Article Outline

1. Introduction
2. Materials and methods
2.1. Chemicals
2.2. Animals
2.3. Induction of experimental colitis in rats
2.4. Assessment of colitis
2.4.1. Macroscopic scoring
2.4.2. Histopathological study
2.5. Biochemical study
2.6. Determination of myeloperoxidase activity
2.7. Measurement of interleukin-1β production
2.8. Measurement of tumor necrosis factor-α
2.9. Determination of reduced glutathione
2.10. Statistical analysis
3. Results
3.1. Macroscopic results
3.2. Microscopic results
3.3. Myeloperoxidase activity
3.4. Interleukin-1β concentrations
3.5. Tumor necrosis factor-α concentrations
3.6. Reduced glutathione concentrations
4. Discussion
References






Corresponding Author Contact InformationCorresponding author. Tel.: +966 1 4786768; fax: +966 1 467 9289.

Pharmacological Research
Volume 53, Issue 4, April 2006, Pages 324-330
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.